Price T Rowe Associates Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 76,498 shares of ARWR stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,498

Previous 73,898 3.52%

Holding current value

$1.42 Million

Previous $1.92 Million 22.85%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.36 - $29.54 $50,336 - $76,804	2,600 Added 3.52%	76,498 $1.48 Million
Q2 2024 Aug 14, 2024	BUY	$21.87 - $28.24 $60,404 - $77,998	2,762 Added 3.88%	73,898 $1.92 Million
Q1 2024 May 15, 2024	BUY	$27.21 - $39.48 $287,555 - $417,224	10,568 Added 17.45%	71,136 $2.04 Million
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $211,576 - $309,679	9,980 Added 19.73%	60,568 $1.85 Million
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $108,415 - $149,299	-4,138 Reduced 7.56%	50,588 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $68,082 - $111,974	2,706 Added 5.2%	54,726 $1.95 Million
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $29,836 - $48,522	1,260 Added 2.48%	52,020 $1.32 Million
Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $3,416 - $4,948	-122 Reduced 0.24%	50,760 $2.06 Million
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $139,142 - $226,863	4,696 Added 10.17%	50,882 $1.68 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $71,003 - $129,308	-2,555 Reduced 5.24%	46,186 $1.63 Million
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $161,808 - $285,757	4,084 Added 9.15%	48,741 $2.24 Million
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $174,850 - $248,355	-3,010 Reduced 6.31%	44,657 $2.96 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $7,472 - $10,874	128 Added 0.27%	47,667 $2.98 Million
Q2 2021 Aug 16, 2021	SELL	$62.15 - $90.32 $214,914 - $312,326	-3,458 Reduced 6.78%	47,539 $3.94 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $274,234 - $404,400	-4,470 Reduced 8.06%	50,997 $3.38 Million
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $2.43 Million - $4.74 Million	55,467 New	55,467 $4.26 Million

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Arrowhead Pharmaceuticals, Inc. Transaction History